Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Oxaliplatin
Related studies linked through entity extraction aliases.
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage I Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for High Risk Stage II or Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Title XELOX FOR SALIVARY GLAND CANCERS
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2